Disclosed is a cosmetic or dermatological preparation which comprises one or more extracts of Saxifraga oppositifolia (purple saxifrage) and/or one or more extracts of Soldanella alpina (alpine snowbell). The use of these extracts to combat extrinsic and intrinsic skin aging is likewise described.

Tattoo removal is disclosed. In an example, a method for removing tattoo ink from skin or resolving a medical condition related to tattoo ink, includes applying a primary solution of beta glucan to a treatment area having tattooed skin. The primary solution stimulates the skin in the treatment area to enhance removal of the tattoo ink from the skin. The example method also includes coating the treatment area with a secondary solution. The secondary solution may have an absorbent material to draw in loose ink. The example method also includes disrupting a skin barrier in the treatment area by a needle or ablative device to improve penetration of at least one of the primary solution and the secondary solution.

The present invention relates generally to cosmetic compositions and methods that can be used to increase skin hydration, increase adenosine triphosphate (ATP) production in skin, increase antioxidant capacity of skin, reduce glycation of skin, or a combination thereof. In particular, topical application of the compositions to skin increases adenosine triphosphate (ATP) production in skin by at least 10%, increases antioxidant capacity of skin, and/or reduces glycation of skin by at least 50%. In particular, the compositions can include Chamomilla recutita (Matricaria) flower extract, Vitis vinifera (Grape) seed extract, hydrolyzed sodium hyaluronate, Natural Moisturizing Factors (NMF), and optionally carnosine.

The present invention relates to a meristematic cell line selected from tissue, preferably callus tissue, of a plant belonging to the genus Rosa. The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The meristematic cell line is characterized by a high polysaccharide content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or of a derivative thereof.

The present invention relates to a meristematic cell line selected from tissue, preferably callus tissue, of a plant belonging to the genus Rosa. The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The meristematic cell line is characterized by a high polysaccharide content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or of a derivative thereof.

In some embodiments, a formulation may include one or more of a lipid-soluble vitamin C compound, derivative, or analog, a cinnamic acid derivative, one or more lipid-soluble vitamin E compounds, and a lipid-based carrier. In some embodiments, the cinnamic acid may include one or more of p-coumaric acid, ferulic acid, caffeic acid, sinapinic acid, combinations thereof, and cis and trans isomers thereof. In some embodiments, the vitamin E compounds may alpha, beta, delta and gamma tocotrienols.

In some embodiments, a formulation may include one or more of a lipid-soluble vitamin C compound, derivative, or analog, a cinnamic acid derivative, one or more lipid-soluble vitamin E compounds, and a lipid-based carrier. In some embodiments, the cinnamic acid may include one or more of p-coumaric acid, ferulic acid, caffeic acid, sinapinic acid, combinations thereof, and cis and trans isomers thereof. In some embodiments, the vitamin E compounds may alpha, beta, delta and gamma tocotrienols.

The present disclosure generally relates to novel cosmetic and/or pharmaceutical formulations and methods of using them. The present formulations contain protective compounds that have been found to significantly reduce the dermal irritation following contact with stinging Cnidaria. These formulations are applied to the skin prior to entering the environment of Cnidaria. In some embodiments, the protective compounds include a rubidium salt, a monocyclic monoterpenoid, and C.sub.7 to C.sub.9 aliphatic alcohols.

The present disclosure generally relates to novel cosmetic and/or pharmaceutical formulations and methods of using them. The present formulations contain protective compounds that have been found to significantly reduce the dermal irritation following contact with stinging Cnidaria. These formulations are applied to the skin prior to entering the environment of Cnidaria. In some embodiments, the protective compounds include a rubidium salt, a monocyclic monoterpenoid, and C.sub.7 to C.sub.9 aliphatic alcohols.

Provided is a male cleanser including a skin conditioner, a solvent, a humectant, a viscosity increasing agent, a surfactant, a preservative, a chelating agent, and perfume, wherein the skin conditioner includes a Maca root extract, a natural extract, niacinamide, glyceryl acrylate/acrylic acid copolymer, hyaluronic acid, arginine, hydrolyzed collagen, sucrose distearate, hydrogenated lecithin, and dimethicone.